CANCER BIOL THER 润色咨询

CANCER BIOLOGY & THERAPY

出版年份:2002 年文章数:2468 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:0.8% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=f1f22922, cover=https://img.medsci.cn/images/journal/cover/2021/kdA_202109271314373680.jpg, fullname=CANCER BIOLOGY & THERAPY, abbr=CANCER BIOL THER, pyear=2002, frequence=Monthly, articleNumbers=2468, citedSelf2015=0.8, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均3.31月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=1538-4047, greenSci=https://www.greensci.net/search?kw=1538-4047, scijournal=https://www.scijournal.org/impact-factor-of-CANCER-BIOL-THER.shtml, medsciHotlightString=null, medsciHotlightRealtime=11.607, medsciHotlight=16.845, medsciHotlight5year=22.1251, citescore=0.0, hIndex=113, impactFactor=3.6, orgnization=Landes Bioscience, orgnizationUrl=http://www.tandfonline.com, country=United States, countryCn=美国, isOa=3, isOaString=部分OA, sciScie=Science Citation Index Expanded, bigclassCas=医学 3区, smallclassCas=医学 3 区, website=https://www.tandfonline.com/loi/kcbt20#.V4he8kz9cSQ, websiteHits=24703, guideForAuthor=http://www.tandfonline.com/action/authorSubmission?show=instructions&journalCode=kcbt20, guideForAuthorHits=1635, submitWebsite=http://cbt.msubmit.net/cgi-bin/main.plex, submitWebsiteHits=15295, content=<div style="box-sizing: border-box; color: rgb(51, 51, 51); font-family: "Open Sans", sans-serif; font-size: 16px;"><div style="box-sizing: border-box;"><b style="box-sizing: border-box;">Impact Factor: 3.294</b></div><div style="box-sizing: border-box;"><b style="box-sizing: border-box;">Five-Year Impact Factor: 3.380</b></div><div style="box-sizing: border-box;">© 2017 Thomson Reuters, <i style="box-sizing: border-box;">Journal Citation Reports</i> ® for 2016 ranks <i style="box-sizing: border-box;">Cancer Biology & Therapy</i> 92 out of 217 in Oncology.</div></div><div style="box-sizing: border-box; color: rgb(51, 51, 51); font-family: "Open Sans", sans-serif; font-size: 16px;"><b style="box-sizing: border-box;"><br style="box-sizing: border-box;">Aims & Scope:</b> Cancer, the second leading cause of death, is a heterogenous group of over 100 diseases. Cancer is characterized by disordered and deregulated cellular and stromal proliferation accompanied by reduced cell death with the ability to survive under stresses of nutrient and growth factor deprivation, hypoxia, and loss of cell-to-cell contacts. At the molecular level, cancer is a genetic disease that develops due to the accumulation of mutations over time in somatic cells. The phenotype includes genomic instability and chromosomal aneuploidy that allows for acceleration of genetic change. Malignant transformation and tumor progression of any cell requires immortalization, loss of checkpoint control, deregulation of growth, and survival. A tremendous amount has been learned about the numerous cellular and molecular genetic changes and the host-tumor interactions that accompany tumor development and progression. It is the goal of the field of Molecular Oncology to use this knowledge to understand cancer pathogenesis and drug action, as well as to develop more effective diagnostic and therapeutic strategies for cancer. This includes preventative strategies as well as approaches to treat metastases. With the availability of the human genome sequence and genomic and proteomic approaches, a wealth of tools and resources are generating even more information. The challenge will be to make biological sense out of the information, to develop appropriate models and hypotheses and to translate information for the clinicians and the benefit of their patients. <i style="box-sizing: border-box;">Cancer Biology & Therapy</i> aims to publish original research on the molecular basis of cancer, including articles with translational relevance to diagnosis or therapy. We will include timely reviews covering the broad scope of the journal. The journal will also publish op-ed pieces and meeting reports of interest. The goal is to foster communication and rapid exchange of information through timely publication of important results using traditional as well as electronic formats. The journal and the outstanding Editorial Board will strive to maintain the highest standards for excellence in all activities to generate a valuable resource.</div>, totalCites=8887, brief=CANCER BIOL THER杂志医学行业,“<strong><a target="_blank" href="/sci/index.do?smallclass=肿瘤学" >肿瘤学</a></strong>”子行业的中等级别杂志, articleType=论著为主,其它类型文章约占5-10%, medsciHeat=<span style="color: #990000;">暗红</span>, medsciComment=CANCER BIOL THER杂志级别还可以,但是相对来说,比较冷门,关注人数偏少,有些可能是国内不太熟悉,但该杂志在国际仍然有相当知晓度的。因为缺少中国人投稿,稿源可能未必丰富,发表有可能有很大的机会哦。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=f1f22922'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=119, tagName=肿瘤, createdHits=63), ImpactFactorTagDto(id=429, tagName=肝癌, createdHits=3), ImpactFactorTagDto(id=1014, tagName=耐药, createdHits=3), ImpactFactorTagDto(id=56299, tagName=新药或中药, createdHits=2), ImpactFactorTagDto(id=19505, tagName=肿瘤生物学, createdHits=2), ImpactFactorTagDto(id=3941, tagName=肿瘤治疗, createdHits=1), ImpactFactorTagDto(id=516, tagName=癌症, createdHits=1), ImpactFactorTagDto(id=42025, tagName=免疫相关, createdHits=1), ImpactFactorTagDto(id=42071, tagName=肿瘤学基础, createdHits=1), ImpactFactorTagDto(id=2964, tagName=分子生物学, createdHits=1), ImpactFactorTagDto(id=1542, tagName=基因治疗, createdHits=1), ImpactFactorTagDto(id=19511, tagName=分子影像, createdHits=1), ImpactFactorTagDto(id=41156, tagName=肿瘤基础研究, createdHits=1), ImpactFactorTagDto(id=2211, tagName=缺氧, createdHits=1), ImpactFactorTagDto(id=24123, tagName=临床肿瘤, createdHits=1), ImpactFactorTagDto(id=1559, tagName=肿瘤学, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=2.96), GetImpactFactorCiteScoreListResponse(year=2017, citescore=3.19), GetImpactFactorCiteScoreListResponse(year=2018, citescore=3.07), GetImpactFactorCiteScoreListResponse(year=2019, citescore=5.4), GetImpactFactorCiteScoreListResponse(year=2020, citescore=0.0)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=18.097), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=15.63), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=15.372), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=12.371), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=11.607)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Molecular Medicine , rank=66/165), GetImpactFactorCiteScoreGradeResponse(smallClass=Pharmacology , rank=83/301), GetImpactFactorCiteScoreGradeResponse(smallClass=Cancer Research , rank=89/198), GetImpactFactorCiteScoreGradeResponse(smallClass=Oncology , rank=95/331)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=ONCOLOGY - SCIE , rank=101/244)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1538-4047[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=Cancer Biology & Therapy[ta], article_number=56, article_number_cn=30, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
CANCER BIOL THER/CANCER BIOLOGY & THERAPY
ISSN
1538-4047
影响指数话题
预警等级
MedSci期刊指数
11.607 (MedSci实时期刊指数) | 22.1251 (5年期刊指数)
CiteScore值
0.0
h-index
113
h5-median
暂无数据
出版社/管理机构
杂志由 Landes Bioscience 出版或管理
出版国家/地区
United States 美国
出版周期
Monthly
出版年份
2002
是否OA
部分OA
被收录情况
Science Citation Index Expanded
JCR分区
ONCOLOGY - SCIE 101/244
中科院分区
大类:医学 3区
小类:医学 3 区